China: A recent randomized clinical trial has highlighted the potential benefits of intraoperative esketamine in reducing ...
Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.
The American Psychiatric Association (APA) named Mark Rapaport, MD, of the University of Utah, as the medical society's next ...
Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
In reality, most people living on the street are not uniquely immune to mental health interventions — they are uniquely ...
It is now approved for adults with treatment-resistant depression (TRD) who have cycled through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster ...
Intraoperative esketamine infusion significantly reduced the incidence of postpartum depression (PPD) at 6 weeks post partum ...
6d
Hosted on MSNSupernus’s stock sinks after depression drug fails trialSupernus Pharmaceutical’s stock declined following the release of disappointing Phase IIb trial results for SPN-820, an ...
I am also looking at the most innovative new treatments for treatment resistant depression (Esketamine and ketamine troches) and Buprenorphine for chronic pain, Alpha-stim for anxiety, depression ...
Trump’s “first buddy” Elon Musk made a lively, chaotic and unpredictable appearance at the Conservative Political Action ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results